ADS-ADEA 2016* Clinical Science
Chairs: Elizabeth Barr & N Wah Cheung
Metabolic subtypes and all-cause and cardiovascular mortality in patients with type 1 diabetes (the FinnDiane Study) (#3)
8:30 AM
Therapeutic inertia for glycaemic and blood pressure control in patients with T2DM and the cardiovascular consequences: A Longitudinal study on 1.1 million patients (#4)
8:45 AM
Dementia risk factors differ by age at onset of type 2 diabetes mellitus: The Fremantle Diabetes Study Phase I (#5)
9:00 AM
Proton pump inhibitor use, mortality and endothelial dysfunction in type 2 diabetes: The Fremantle Diabetes Study Phase II (#6)
9:15 AM
The Prevalence of Diabetes Mellitus and its Association with Stroke Inpatient Outcomes (#7)
9:30 AM
Prevalence of diabetes amongst patients hospitalised with decompensated heart failure and their outcomes (#8)
9:45 AM
Utilisation of prehospital emergency medical services for hyperglycaemia (#9)
10:00 AM
Pneumococcal vaccination and incident pneumonia in type 2 diabetes: The Fremantle Diabetes Study Phase II (#10)
10:15 AM